Champions Oncology (CSBR) Reports Q3 Loss of $0.21/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. CVS

Go back to Champions Oncology (CSBR) Reports Q3 Loss of $0.21/Share

Champions Oncology Reports Results for the Third Quarter Ended January 31, 2016

March 15, 2016 8:30 AM EDT

HACKENSACK, N.J., March 15, 2016 /PRNewswire/ -- Champions Oncology, Inc. (NASDAQ: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced its financial results for the third quarter ended January 31, 2016.

Third Quarter and Recent Business Highlights:

Delivered record core bookings of new contracts to pharma and biotech customers TOS revenue growth of 55% Launched AML product line Reduced cash burn to under $1M for the quarter Initiated sponsored correlative trial of... More